Personalized medicine puts a new face on drug research

02/7/2013 | Wall Street Journal, The

Drugmakers increasingly use genetic data to select for early-stage clinical trials patients who are likely to benefit from the experimental drug. The strategy could reduce the time it takes to get a new drug approved with less money wasted on ineffective trials, experts say.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX